Month: July 2026
Cannabis Banking’s Tipping Point: How The Ecosystem Is Preparing
Cannabis banking is heading for major change. Industry leaders reveal how cannabis banking service providers are preparing their clients …
Better cannabis growth stock: Trulieve or Vireo Growth
Trulieve is the more established cannabis multi-state operator, while Vireo Growth has been growing rapidly through acquisitions.
Wyoming Opts Out Of Federal Medical Cannabis Rescheduling
Wyoming Attorney General Keith Kautz has determined that the medical cannabis rescheduling won’t apply to his state.
Investors Are Starting To Ask Cannabis Companies Different Questions
As institutional capital enters cannabis, workforce risk is reshaping valuations. Learn why HR compliance and culture now drive M&A, diligence,…
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts. Click…
Maryland loosens rule for investing in some cannabis businesses
Maryland cannabis leaders hope that looser ownership rules could attract more outside investment, but some experts say a larger issue…
Why Is Trulieve Cannabis (NYSE:TRLV) Watching NYSE Composite?
Explore Trulieve Cannabis (NYSE:TRLV), operating across regulated cannabis markets, with insights into business operations, Florida presence, and the company’s role…
Beverage company bets on cannabis-based epilepsy drug, secures $1 million investment
The Fort Lauderdale company is expanding beyond beverages with a deal that gives it global rights to an epilepsy therapy…
Is Canopy Growth stock finally worth buying after losing 99% of its value?
A lower stock price doesn’t eliminate investment risk.
D.C. Circuit challenge and DEA hearing put federal cannabis rescheduling to the test
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP examine the dual developments over the federal government’s cannabis…
Recent Comments